Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802151 · ClinicalTrials.gov registry record · NA
Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT01802151 is a NA study that has completed, run by University of Florida. The registered enrollment target is 83 participants.
The verdict
NCT01802151, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of three doses of the probiotic B. subtilis (Bacillus subtilis R0179) delivered in capsules on gastrointestinal and general wellness in healthy young adults, survival through the gastrointestinal tract and impact on intestinal microbes.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT B. subtilis R0179
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01802151
The ClinicalTrials.gov registry entry for NCT01802151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01802151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01802151 about?
NCT01802151 is a clinical study titled "Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults". The purpose of this study is to evaluate the effect of three doses of the probiotic B. subtilis (Bacillus subtilis R0179) delivered in capsules on gastrointestinal and general wellness in healthy young adults, survival through the gastrointestinal tract and impact on intestinal microbes.
What is the current status of trial NCT01802151?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2012-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01802151?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), B. subtilis R0179 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01802151?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.